Wellnex Life
- Short interest
- 0.01%
- +0.01 pp 30d
- as of 7 Aug 2026
- Reported shorts
- 9.3K
- Shares on issue
- 73.027M
Wellnex Life (WNX) News
Latest articles and price-sensitive announcements with AI sentiment classification.
ASXChange of Director's Interest Notice
director_dealing announcement
Google NewsDoes Wellnex Life (ASX:WNX) look leaner after Pain Away exit? - Kalkine Media
Does Wellnex Life (ASX:WNX) look leaner after Pain Away exit? Kalkine Media
Completion and Settlement of Sale of Pain Away
other announcement
Appendix 4G and Corporate Governance Statement
other announcement
Wellnex Life Releases FY26 Annual Report
other announcement
KalkineWellnex Life Limited Schedules Extraordinary General Meeting to Approve Sale of Pain Away Business
Wellnex Life Limited (ASX:WNX) has announced an Extraordinary General Meeting set for 10:00 am AEST on Tuesday, 8 September 2026, at Level 23, Rialto South Tower, 525 Collins Street, Melbourne. Shareholders will vote on the proposed disposal of the company’s Pain Away Business during this meeting. Key Highlights Extraordinary General Meeting to be held at 10:00 am AEST (1:00 am BST) on Tuesday, 8 September 2026, at Rialto South Tower, Melbourne The sole agenda item is Resolution 1, an ordin...
Wellnex Life (ASX:WNX) Share Price Jumps as Turnaround Progress Draws Attention - Kalkine
Wellnex Life (ASX:WNX) Share Price Jumps as Turnaround Progress Draws Attention Kalkine
Wellnex Life offloads Pain Away brand to Japan's Rohto Pharmaceutical subsidiary for up to $21.3m
Melbourne-based consumer healthcare group Wellnex Life (ASX: WNX) plans to wipe out company debt with the sale of its Pain Away topical analgesics brand to Mentholatum Australasia, a subsidiary of Tokyo Stock Exchange-listed Rohto Pharmaceutical, for up to $21.3 million. The cash deal comprises $19.8 million in upfront consideration and an earn...
Appendix 4C and Quarterly Report for Jun 2026 Quarter
other announcement
Wellnex Life (ASX:WNX): Is This Consumer Health Stock Ready for a Recovery Story? - Kalkine
Wellnex Life (ASX:WNX): Is This Consumer Health Stock Ready for a Recovery Story? Kalkine